VirnetX (VHC) Insider Thomas O'Brien Buys 7,500 Shares

Thomas O'Brien recently increased his stake in VHC by purchasing 7,500 shares on June 11, 2026. This insider transaction was not part of a pre-planned trading program and reflects O'Brien's interest in the company.

Insider Buying and Selling at VirnetX Holding Corporation

On June 11, 2026, several insiders, including Thomas O'Brien, Gary Feiner, Michael Angelo, and Heidy Kingwan Chow, each bought 7,500 shares of VHC. These purchases were made outside of any pre-arranged trading plans. Additionally, O'Brien had previously sold 625 shares on December 3, 2025.

Other Institutional Activity in VHC

Among institutional investors, Vanguard Capital Management LLC opened a new position, acquiring 155,541 shares valued at approximately $2,155,798. Geode Capital Management, LLC increased its holdings by 6,010 shares, bringing its total to 47,933 shares worth about $664,914. Meanwhile, CSENGE Advisory Group slightly increased its position by 117 shares, ending with 68,360 shares valued at $964,553. In contrast, Stanley-Laman Group, Ltd. maintained its holdings without any changes, and BlackRock, Inc. reduced its position by 106 shares to 63,308 shares, valued at approximately $893,269.

VirnetX Holding Corporation Stock Down 1.8%

Shares of VHC traded near $11.79 on Friday. The latest insider activity and institutional moves provide a snapshot of the interest surrounding VHC, although detailed fundamentals and market metrics were not available.

Bottom Line

Thomas O'Brien's recent purchase of VHC shares highlights ongoing insider interest in the company. Such transactions can offer insights into the confidence of those closely associated with the company. As with all 13F filings and insider transactions, these reports are backward-looking and may not represent current positions.